Operating Lease, Payments in USD of Vistagen Therapeutics, Inc. from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2024.
  • Vistagen Therapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $223K, a 8.83% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $800K, a 14.3% increase from 2023.
  • Vistagen Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $700K, a 22.2% decline from 2022.
  • Vistagen Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $900K, a 6.6% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)

Vistagen Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $223K +$18.1K +8.83% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q2 2022 $205K -$20.9K -9.25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q2 2021 $226K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11

Vistagen Therapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $800K +$100K +14.3% Apr 1, 2024 Mar 31, 2025 10-K 2025-06-17
2023 $700K -$200K -22.2% Apr 1, 2023 Mar 31, 2024 10-K 2025-06-17
2022 $900K +$55.7K +6.6% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2021 $844K +$52.7K +6.66% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 $792K Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.